MeiraGTx Holdings PLC banner

Intrinsic Value

The intrinsic value of MeiraGTx Holdings PLC (MGTX) under the Base Case is 14.61 USD per share. Compared with the current market price of 9.33 USD, the stock appears Undervalued by 36% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

MGTX Intrinsic Value
$14.61
Undervaluation 36%
Intrinsic Value
Price $9.33

MGTX is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Monitor MGTX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $11.69
Get notified when the price drops into your buy zone
Intrinsic Value $14.61
Margin of Safety 20% $11.69
Current Price $9.33
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MGTX

Fundamental Analysis

What MeiraGTx Does

Biotechnology Health Care

MeiraGTx Holdings PLC is a biotechnology company that develops gene therapy medicines. Its work focuses on diseases where a missing or faulty gene causes vision loss, mouth and salivary gland problems, or other serious disorders. The company’s main job is to design gene-based treatments, run clinical studies, and work through the long process of getting those therapies approved.

Headquarters
United States of America US
Employees
400
IPO date
Jun 8, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
MeiraGTx Holdings PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

MGTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one MGTX stock?

The intrinsic value for MeiraGTx Holdings PLC (MGTX) under the Base Case is 14.61 USD.

Is MGTX stock undervalued or overvalued?

Compared with the current market price of 9.33 USD, the stock appears Undervalued by 36% .

Back to Top